Skip to main content
Top
Published in: European Journal of Nutrition 5/2021

01-08-2021 | Lactation | Original Contribution

Buttermilk: an important source of lipid soluble forms of choline that influences the immune system development in Sprague–Dawley rat offspring

Authors: Jessy Azarcoya-Barrera, Catherine J. Field, Susan Goruk, Alexander Makarowski, Jonathan M. Curtis, Yves Pouliot, René L. Jacobs, Caroline Richard

Published in: European Journal of Nutrition | Issue 5/2021

Login to get access

Abstract

Purpose

To determine the effect of feeding buttermilk-derived choline metabolites on the immune system development in Sprague–Dawley rat pups.

Methods

Sprague–Dawley dams were randomized to one of the three diets containing 1.7 g/kg choline: 1-Control (100% free choline (FC)), 2-Buttermilk (BM, 37% phosphatidylcholine (PC), 34% sphingomyelin (SM), 17% glycerophosphocholine (GPC), 7% FC, 5% phosphocholine), and 3-Placebo (PB, 50% PC, 25% FC, 25% GPC) until the end of the lactation period. At weaning, pups continued on the same diet as their mom. Cell phenotypes and cytokine production by mitogen-stimulated splenocytes isolated from 3- and 10-week-old pups were measured.

Results

At 3 weeks, BM-pups had a higher proportion of cytotoxic T cells (CTL; CD3 + CD8 +) while both BM- and PB-pups had an increased proportion of cells expressing CD28 + , CD86 + and CD27 + (all p > 0.05). Following ConA stimulation, splenocytes from BM- and PB-pups produced more TNF-α and IFN-γ and after LPS stimulation produced more IL-10 and TNF-α (all p > 0.05). Starting at week 6 of age, BM-pups had a higher body weight. At 10 weeks, both the BM- and PB-pups had a higher proportion of CTL expressing CD27 + . After ConA stimulation, splenocytes from BM- and PB-pups produced more IL-2, IFN-γ and IL-6 and more IL-10 after LPS stimulation (all p > 0.05).

Conclusion

The proportion of lipid soluble forms of choline in the diet during lactation and weaning periods influence the immune system development in rat offspring.
Appendix
Available only for authorised users
Literature
5.
go back to reference Yaqoob P, Calder P (2011) The immune and inflammatory SYSTEMS. In: Lanham-New S, MacDonald IM, Roche HM (eds) Nutrition and metabolism. Wiley-Blackwell, Oxford Yaqoob P, Calder P (2011) The immune and inflammatory SYSTEMS. In: Lanham-New S, MacDonald IM, Roche HM (eds) Nutrition and metabolism. Wiley-Blackwell, Oxford
14.
go back to reference Vanderghem C, Bodson S, Danthine S, Paquot M, Deroanne C, Blecker C (2010) Milk fat globule membrane and buttermilks: From composition to valorization. Biotechnologie, Agronomie, Société et Environnement, p 14 Vanderghem C, Bodson S, Danthine S, Paquot M, Deroanne C, Blecker C (2010) Milk fat globule membrane and buttermilks: From composition to valorization. Biotechnologie, Agronomie, Société et Environnement, p 14
21.
go back to reference Field CJ, Thomson CA, Van Aerde JE, Parrott A, Euler A, Lien E et al (2000) Lower proportion of CD45R0+ cells and deficient interleukin-10 production by formula-fed infants, compared with human-fed, is corrected with supplementation of long-chain polyunsaturated fatty acids. J Pediatr Gastroenterol Nutr 31(3):291–299CrossRefPubMed Field CJ, Thomson CA, Van Aerde JE, Parrott A, Euler A, Lien E et al (2000) Lower proportion of CD45R0+ cells and deficient interleukin-10 production by formula-fed infants, compared with human-fed, is corrected with supplementation of long-chain polyunsaturated fatty acids. J Pediatr Gastroenterol Nutr 31(3):291–299CrossRefPubMed
34.
go back to reference Goldsby R, Kindt T, Osborne B, Kuby J (2003) Kuby Immunology. W.H. Freeman and Company, USA Goldsby R, Kindt T, Osborne B, Kuby J (2003) Kuby Immunology. W.H. Freeman and Company, USA
37.
go back to reference Kasahara T, Hooks JJ, Dougherty SF, Oppenheim JJ (1983) Interleukin 2-mediated immune interferon (IFN-gamma) production by human T cells and T cell subsets. J Immunol 130(4):1784–1789CrossRefPubMed Kasahara T, Hooks JJ, Dougherty SF, Oppenheim JJ (1983) Interleukin 2-mediated immune interferon (IFN-gamma) production by human T cells and T cell subsets. J Immunol 130(4):1784–1789CrossRefPubMed
39.
41.
go back to reference Fiorentino DF, Zlotnik A, Mosmann TR, Howard M, O’Garra A (1991) IL-10 inhibits cytokine production by activated macrophages. J Immunol 147(11):3815–3822CrossRefPubMed Fiorentino DF, Zlotnik A, Mosmann TR, Howard M, O’Garra A (1991) IL-10 inhibits cytokine production by activated macrophages. J Immunol 147(11):3815–3822CrossRefPubMed
43.
go back to reference Walker W, Aste-Amezaga M, Kastelein RA, Trinchieri G, Hunter CA (1999) IL-18 and CD28 use distinct molecular mechanisms to enhance NK cell production of IL-12-induced IFN-gamma. J Immunol 162(10):5894–5901CrossRefPubMed Walker W, Aste-Amezaga M, Kastelein RA, Trinchieri G, Hunter CA (1999) IL-18 and CD28 use distinct molecular mechanisms to enhance NK cell production of IL-12-induced IFN-gamma. J Immunol 162(10):5894–5901CrossRefPubMed
Metadata
Title
Buttermilk: an important source of lipid soluble forms of choline that influences the immune system development in Sprague–Dawley rat offspring
Authors
Jessy Azarcoya-Barrera
Catherine J. Field
Susan Goruk
Alexander Makarowski
Jonathan M. Curtis
Yves Pouliot
René L. Jacobs
Caroline Richard
Publication date
01-08-2021
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Nutrition / Issue 5/2021
Print ISSN: 1436-6207
Electronic ISSN: 1436-6215
DOI
https://doi.org/10.1007/s00394-020-02462-3

Other articles of this Issue 5/2021

European Journal of Nutrition 5/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.